Trial Assessing the Impact on Facial Skin Quality, Hydration, and Skin Barrier of Three (3) Hydrafacial Treatments in Adults of All Skin Types.

Completed · Phase 4

Conditions studied: Cutis Laxa Facialis, Xeroderma

In brief

This is a phase IV, unblinded, open-label study assessing the impact on skin quality, hydration, and barrier of three (3) Hydrafacial treatments in healthy adults of Fitzpatrick Skin Types I \& II, III, IV, V \& VI, 30 to 55 years of age. Efficacy and subject satisfaction will be assessed, before and after three (3) HF treatments, in 6 patient cohorts, each cohort defined by FST I-VI.

Key facts

Study ID

NCT05932732

Run by

Austin Institute for Clinical Research

People needed

27

Starts

2023-11-20

Expected to finish

2024-10-09

Last updated by the study team

2024-10-24

Who can join

Age: 30 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy males and females of Fitzpatrick skin types I-VI 30-55 years of age.
• No known medical conditions that in the investigator's opinion may interfere with study participation.
• Agrees to abstain from starting a new skincare product for the duration of trial participation.
• Willingness to cooperate and participate by following study requirements.
• Individuals must sign an informed consent and photography consent.

You may not qualify if…

• History of any cancer excluding fully treated basal cell carcinoma or squamous cell carcinoma in situ in the treatment area.
• Presence of untreated precancerous lesions in the treatment area.
• Presence of sunburn, moderate to pronounced suntan, uneven skin tone, tattoos, scars or other disfiguration in the treatment area.
• Any cutaneous condition that may affect study adherence or ability to assess endpoints, as determined by the investigator, to include, but not limited to, uncontrolled psoriasis, atopic dermatitis, severe photodamage, and uncontrolled acne.
• Subject is pregnant, nursing, or planning to become pregnant.
• Significant past medical history of hepatic, hypertensive, renal, cardiac, pulmonary, digestive, hematological, neurological, or psychiatric disease, which in the opinion of the Investigator would compromise the safety of the subject.
• Currently participating in another clinical trial.
• History of Photo Epilepsy.

Where it is running

• Austin Institute for Clinical Research, Inc. — Houston, Texas, United States
• Austin Institute for Clinical Research, Inc. — Pflugerville, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.